A Pilot Trial of Adalimumab for the Treatment of Osteoarthritis

Completed · Phase 2

Conditions studied: Osteoarthritis

In brief

A 12 week trial of Adalimumab in subjects with active erosive inflammatory OA who have ahd an inadequate response to NSAID therapy

Key facts

Study ID

NCT00185562

Run by

Stanford University

People needed

12

Starts

2005-06-01

Expected to finish

2006-01-01

Last updated by the study team

2006-03-24

Who can join

Age: 45 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 45 or older, >/=2 tender and 2 swollen joints, inadequate response to NSAID therapy, hand radiographs with evidence of erosive changes, acceptable form of birth control

You may not qualify if…

• Autoimmune arthropathy, History of psoriasis, Previous TNF therapy, current use of any DMARD, evidence of TB, history of Hep C, B, or HIV

Where it is running

• Stanford University — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.